Aquestive Therapeutics (AQST) Tax Rate (2023 - 2024)
Aquestive Therapeutics (AQST) posted quarterly Tax Rate of 0.08% for Q4 2024, up 134.0% year-over-year from 0.04% in Q1 2024, and up 106.5% quarter-over-quarter from 1.26% in Q4 2023.
Aquestive Therapeutics (AQST) Tax Rate (2023 - 2024) Analysis & Trends
Aquestive Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 0.08% for Q4 2024.
- In Q4 2024, Tax Rate rose 134.0% year-over-year to 0.08%; the TTM figure through Mar 2025 stood at 0.03% (up 88.0% YoY), while the FY2024 annual figure was 0.03%, up 324.0% from the prior year.
- Tax Rate for Q4 2024 stood at 0.08%, up from 1.26% in the prior quarter.
- The five-year high for Tax Rate was 6.44% in Q3 2023, with the low at 5.16% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -26.59% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -30.40% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 10.65% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -85.63% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 10.97% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.57% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.08% |
| Dec 31, 2024 | 0.08% |
| Dec 31, 2024 | 0.08% |
| Dec 31, 2023 | -1.26% |
| Dec 31, 2023 | -1.26% |
| Dec 31, 2023 | -1.26% |
| Sep 30, 2023 | 6.44% |
| Sep 30, 2023 | 6.44% |
| Sep 30, 2023 | 6.44% |
| Jun 30, 2023 | -5.16% |
| Jun 30, 2023 | -5.16% |
| Jun 30, 2023 | -5.16% |